Brian J Day Selected Research

Acetylcholinesterase

1/2019

Neuroprotective effects of a catalytic antioxidant in a rat nerve agent model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian J Day Research Topics

Disease

22	Inflammation (Inflammations) 01/2023 - 05/2008
11	Lung Diseases (Lung Disease) 05/2024 - 04/2004
10	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2004
9	Infections 02/2023 - 04/2004
7	Lung Injury 05/2024 - 01/2003
7	Status Epilepticus (Complex Partial Status Epilepticus) 04/2024 - 10/2015
7	Neuroinflammatory Diseases 04/2024 - 01/2017
6	Respiratory Hypersensitivity 01/2023 - 10/2010
6	Cystic Fibrosis (Mucoviscidosis) 06/2022 - 04/2004
5	Neoplasms (Cancer) 05/2024 - 07/2006
5	Chronic Obstructive Pulmonary Disease (COPD) 02/2023 - 06/2009
5	Ischemia 04/2015 - 10/2002
4	Epilepsy (Aura) 04/2024 - 03/2012
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 04/2007
4	Asthma (Bronchial Asthma) 10/2020 - 01/2003
4	Berylliosis 01/2018 - 10/2004
3	Virus Diseases (Viral Diseases) 02/2023 - 01/2022
3	Wounds and Injuries (Trauma) 01/2019 - 07/2003
3	Hypoxia (Hypoxemia) 02/2007 - 01/2003
2	Cognitive Dysfunction 08/2023 - 10/2015
2	Airway Obstruction (Choking) 01/2023 - 01/2020
2	Parkinsonian Disorders (Parkinsonism) 01/2021 - 04/2007
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 10/2010
2	Temporal Lobe Epilepsy 12/2017 - 10/2015
2	Cardiotoxicity 04/2015 - 11/2009
2	Acute Lung Injury 07/2013 - 09/2003
2	Breast Neoplasms (Breast Cancer) 04/2012 - 02/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012 - 04/2007
2	Fibrosis (Cirrhosis) 11/2009 - 02/2008
2	Cardiomyopathies (Cardiomyopathy) 04/2007 - 05/2002
1	Brain Diseases (Brain Disorder) 04/2024
1	Persistent Infection 06/2022
1	Human Influenza (Influenza) 01/2022
1	Pneumonia (Pneumonitis) 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2018

Drug/Important Bio-Agent (IBA)

30	AntioxidantsIBA 04/2024 - 10/2002
16	Glutathione (Reduced Glutathione)IBA 04/2024 - 05/2002
12	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 10/2002
10	AEOL 10150IBA 08/2023 - 10/2002
9	CytokinesIBA 01/2023 - 01/2003
8	Proteins (Proteins, Gene)FDA Link 02/2023 - 04/2004
8	MetalloporphyrinsIBA 01/2021 - 10/2002
7	SmokeIBA 10/2015 - 03/2006
5	Oxidants (Oxidizing Agents)IBA 01/2019 - 01/2003
5	BerylliumIBA 01/2018 - 10/2004
4	2-chloroethyl ethyl sulfideIBA 07/2014 - 03/2009
3	Mustard Gas (Sulfur Mustard)IBA 05/2024 - 05/2010
3	Glutamate-Cysteine LigaseIBA 04/2024 - 02/2012
3	ManganeseIBA 01/2024 - 02/2007
3	PorphyrinsIBA 08/2023 - 02/2007
3	Pilocarpine (Ocusert)FDA LinkGeneric 08/2023 - 07/2017
3	Nerve AgentsIBA 08/2023 - 07/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2023 - 03/2003
3	Particulate MatterIBA 01/2023 - 10/2020
3	Thioredoxin-Disulfide ReductaseIBA 01/2020 - 01/2012
3	Superoxide DismutaseIBA 03/2012 - 03/2003
3	FlavonoidsIBA 01/2012 - 07/2006
3	Mitochondrial DNA (mtDNA)IBA 04/2007 - 01/2004
3	Superoxides (Superoxide)IBA 03/2003 - 12/2002
2	Dimercaprol (B.A.L.)FDA Link 04/2024 - 01/2017
2	Kainic Acid (Kainate)IBA 04/2024 - 08/2023
2	EnzymesIBA 04/2024 - 01/2012
2	Isoflurophate (DFP)FDA Link 08/2023 - 01/2018
2	SomanIBA 08/2023 - 01/2019
2	Nicotine FDA Link 02/2023 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 03/2012
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2022
2	thiocyanateIBA 06/2022 - 08/2015
2	Peroxidase (Myeloperoxidase)IBA 01/2020 - 02/2009
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2018 - 10/2010
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 10/2010
2	Chemical Warfare AgentsIBA 01/2016 - 07/2014
2	ChlorineIBA 04/2015 - 10/2010
2	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2013 - 03/2003
2	1,3-dimethylthioureaIBA 07/2013 - 10/2010
2	AEOL 11207IBA 03/2012 - 04/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 11/2009
2	chrysinIBA 01/2012 - 07/2006
2	DNA (Deoxyribonucleic Acid)IBA 11/2010 - 03/2009
2	Therapeutic UsesIBA 04/2007 - 01/2003
2	Oxygen (Dioxygen)IBA 02/2007 - 01/2003
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2006 - 04/2004
1	Cysteamine (Mercaptamine)FDA Link 04/2024
1	Neutralizing AntibodiesIBA 02/2023
1	TNF-Related Apoptosis-Inducing LigandIBA 02/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	Interleukin-13IBA 01/2023
1	E-Cigarette VaporIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Interleukin-33IBA 10/2020
1	MucinsIBA 01/2020
1	Hypochlorous Acid (Hypochlorite)IBA 01/2020
1	AcetylcholinesteraseIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	OrganophosphatesIBA 01/2018
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2018

Therapy/Procedure

15	Therapeutics 05/2024 - 01/2003
1	Injections 08/2023